How To Use CPT Code 0661T

CPT 0661T describes the removal and reimplantation of an anterior segment intraocular nonbiodegradable drug-eluting implant. This article will cover the description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, and examples.

1. What is CPT Code 0661T?

CPT 0661T can be used to describe the procedure of removing and reimplanting an anterior segment intraocular nonbiodegradable drug-eluting implant. This code is used when a provider replaces a previously placed implant with a new one to deliver a controlled rate of medication into the front-most region of the eye to treat conditions like glaucoma.

2. Official Description

The official description of CPT code 0661T is: ‘Removal and reimplantation of anterior segment intraocular nonbiodegradable drug-eluting implant (report medication separately).’

3. Procedure

1. The provider prepares the patient and administers anesthesia.
2. Using an ab interno approach, the provider makes a small incision and examines the anterior chamber angle.
3. The provider removes the previously placed drug-eluting system and replaces it with a new one, potentially targeting the trabecular meshwork.
4. The drug-eluting system may consist of an anchor, drug reservoir, and a membrane for controlled drug release.
5. The provider removes the tools used for removal and reimplantation, completing the procedure.

4. Qualifying circumstances

Patients eligible for CPT 0661T are those who require the removal and reimplantation of an anterior segment intraocular nonbiodegradable drug-eluting implant. This procedure is typically performed to treat conditions such as glaucoma. The provider must use a drug-eluting system that includes an anchor, drug reservoir, and a membrane for controlled drug release.

5. When to use CPT code 0661T

CPT code 0661T should be used when a provider performs the removal and reimplantation of an anterior segment intraocular nonbiodegradable drug-eluting implant. It is important to note that CPT code 0660T should be used for the initial implantation of the device.

6. Documentation requirements

To support a claim for CPT code 0661T, the provider must document the following information:

• Patient’s diagnosis and the need for removal and reimplantation of the drug-eluting implant
• Details of the drug-eluting system used, including the anchor, drug reservoir, and membrane
• Date and duration of the procedure
• Specific steps performed during the removal and reimplantation
• Any complications or additional procedures performed
• Signature of the provider

7. Billing guidelines

When billing for CPT code 0661T, ensure that the procedure involves the removal and reimplantation of an anterior segment intraocular nonbiodegradable drug-eluting implant. Report the medication separately if applicable. It is important to follow the guidelines for reporting CPT code 0661T with other codes, if necessary. Consider using modifier 26 for professional component reporting and modifier TC for technical component reporting, depending on the location of the testing.

8. Historical information

CPT code 0661T was added to the Current Procedural Terminology system on July 1, 2021. There have been no updates to the code since its addition.

9. Examples

1. A provider removes and reimplants an anterior segment intraocular nonbiodegradable drug-eluting implant to treat glaucoma in a patient.
2. During the procedure, the provider replaces a previously placed implant with a new one to deliver medication to the anterior segment of the eye in a patient with a specific eye condition.
3. A provider performs the removal and reimplantation of an anterior segment intraocular nonbiodegradable drug-eluting implant to manage a patient’s ocular condition.
4. In a patient with glaucoma, the provider removes and replaces an anterior segment intraocular nonbiodegradable drug-eluting implant to ensure the controlled release of medication.
5. A provider performs the removal and reimplantation of an anterior segment intraocular nonbiodegradable drug-eluting implant to address a patient’s specific eye disorder.
6. During the procedure, the provider replaces a drug-eluting implant in the anterior segment of the eye to effectively manage the patient’s ocular condition.
7. A patient undergoes the removal and reimplantation of an anterior segment intraocular nonbiodegradable drug-eluting implant to treat their glaucoma.
8. The provider performs the procedure to remove and replace a drug-eluting implant in the patient’s eye, ensuring the controlled release of medication.
9. In a patient with a specific eye condition, the provider removes and reimplants an anterior segment intraocular nonbiodegradable drug-eluting implant to manage their ocular health.
10. A provider performs the removal and reimplantation of an anterior segment intraocular nonbiodegradable drug-eluting implant to address the patient’s glaucoma and ensure the appropriate delivery of medication.